The results revealed that CAG25 treatment certainly decreased the number of nuclear MBNL1 aggregates from day 5 to day 7 in these DM1 myotubes (Supplementary Fig. S10a–c). The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.